Phase 3 Content Plan Internal Reference April 2026
Aubrey Walker
April 23, 2026
internal
Palmetto Peptides — Phase 3 Content Plan
70 articles | 13 weeks | 5–6/week | 0 duplicates verified against 440 existing posts | April 23, 2026
🖨 To save as PDF: Press Ctrl+P / Cmd+P → Save as PDF
Legend: Hub = cross-cluster pillar | Comparison = head-to-head | Supporting = deepens cluster | Commercial = buyer intent | Cornerstone = long-form evergreen | 🆕 = new peptide cluster
🔴 TIER 1 — Weeks 1–2 | GLP-1, Weight Loss & Commercial Intent
Highest search volume + all products carried + buyer-intent = fastest path to sales.
| # | Title | Cluster | Type |
|---|---|---|---|
| 1 | Weight Loss Research Peptides 2026: AOD-9604, Semaglutide, Tirzepatide and Retatrutide | GLP-1 | Hub |
| 2 | GLP-1 Peptide Research Guide 2026: Semaglutide, Tirzepatide, Retatrutide & Cagrilintide Compared | GLP-1 | Hub |
| 3 | How GLP-1 Receptor Agonists Work: Mechanism of Action Across Research Peptides | GLP-1 | Supporting |
| 4 | AOD-9604 vs Semaglutide: Comparing Fat Metabolism Research Approaches | AOD-9604 | Comparison |
| 5 | AOD-9604 vs Retatrutide: HGH Fragment vs Triple Agonist in Weight Research | AOD-9604 | Comparison |
| 6 | Cagrilintide vs Tirzepatide: Comparing Dual vs Single Amylin Agonist Research | Cagrilintide | Comparison |
| 7 | How to Build a Peptide Research Stack: Matching Compounds to Study Goals | General | Commercial |
| 8 | Best Research Peptide Supplier Checklist: 10 Things to Verify Before Ordering | General | Commercial |
🟠 TIER 2 — Weeks 3–5 | PT-141, Melanocortin, GH Peptides, IGF-1
All products carried. Comparison searches = purchase decision stage.
| # | Title | Cluster | Type |
|---|---|---|---|
| 9 | PT-141 vs MT-2: Comparing Melanocortin Peptides in Preclinical Research | PT-141/MT-2 | Comparison |
| 10 | Melanocortin Peptide Research Hub: MC1R, MC3R, MC4R Agonists Compared | PT-141/MT-2 | Hub |
| 11 | PT-141 Research Peptide Dosage Protocols in Animal Model Studies | PT-141 | Supporting |
| 12 | PT-141 Long-Term Stability Research: Storage Conditions and Degradation Data | PT-141 | Supporting |
| 13 | PT-141 Neuropeptide Mechanism: CNS Receptor Binding in Preclinical Models | PT-141 | Supporting |
| 14 | MT-2 Research Peptide 2026: Updated Lab Findings and Protocol Overview | MT-2 | Supporting |
| 15 | Ipamorelin vs Hexarelin: Side-by-Side Preclinical Research Comparison | Ipamorelin | Comparison |
| 16 | Ipamorelin vs Sermorelin: GHRP vs GHRH in Growth Hormone Research | Ipamorelin | Comparison |
| 17 | Ipamorelin + CJC-1295 Stack: Synergistic GH Secretion Research Findings | Ipamorelin | Supporting |
| 18 | Ipamorelin Research Applications in Endocrine Laboratory Studies | Ipamorelin | Supporting |
| 19 | Ipamorelin Purity and Quality Standards: What Research Labs Should Verify | Ipamorelin | Supporting |
| 20 | Ipamorelin Receptor Selectivity: Why It Targets GH Without Cortisol or Prolactin Elevation | Ipamorelin | Supporting |
| 21 | CJC-1295 + Ipamorelin vs Sermorelin: Triple Comparison for GH Research | CJC-1295 | Comparison |
| 22 | CJC-1295 With DAC vs Without DAC: Full Research Protocol Comparison | CJC-1295 | Comparison |
| 23 | GHRH Peptide Research Hub: Sermorelin, CJC-1295, and Tesamorelin Compared | GH Cluster | Hub |
| 24 | IGF-1 LR3 + BPC-157 Research Stack: Tissue Repair Synergy Studies | IGF-1 LR3 | Supporting |
| 25 | IGF-1 LR3 vs MGF: Comparing IGF Variants in Muscle Research Models | IGF-1 LR3 | Comparison |
🟡 TIER 3 — Weeks 5–8 | Trust Builders, Mitochondria, Nootropics, NAD+
Strong search volume + growing categories. Trust content converts skeptical buyers.
| # | Title | Cluster | Type |
|---|---|---|---|
| 26 | What Is a Certificate of Analysis (COA)? Peptide Research Buyer's Guide | General | Commercial |
| 27 | Peptide Purity 98% vs 99%: What the Research Grade Difference Actually Means | General | Commercial |
| 28 | How to Read an HPLC Report for Research Peptides: A Lab Guide | General | Commercial |
| 29 | Lyophilized vs Liquid Peptides: Storage Stability Research Comparison | General | Supporting |
| 30 | SS-31 vs MOTS-C: Comparing Mitochondria-Targeted Research Peptides | SS-31 | Comparison |
| 31 | SS-31 in Cardiac Ischemia Research: What Preclinical Animal Studies Show | SS-31 | Supporting |
| 32 | SS-31 Research Peptide Dosage Protocols in Preclinical Cellular Models | SS-31 | Supporting |
| 33 | SS-31 vs NAD+: Two Approaches to Mitochondrial Support in Research | SS-31 | Comparison |
| 34 | Mitochondrial Research Peptides 2026: SS-31, MOTS-C, and NAD+ Compared | Mitochondria | Hub |
| 35 | Nootropic Research Peptides 2026: Semax, Selank, and Emerging Neuropeptides | Semax/Selank | Hub |
| 36 | Semax + Selank Research Stack: Combining Neuropeptides in Lab Studies | Semax | Supporting |
| 37 | Semax vs BPC-157 for Neuroprotection: Comparing Preclinical Research | Semax | Comparison |
| 38 | Semax Research Protocol Guide: Reconstitution, Storage, and Lab Applications | Semax | Supporting |
| 39 | Semax Receptor Interactions: ACTH-Derived Peptide Binding in Neural Cell Studies | Semax | Supporting |
| 40 | N-Acetyl Semax Amidate: How Modifications Affect Research Outcomes | Semax | Supporting |
| 41 | NAD+ vs NMN vs NR: Research Comparison in Cellular Longevity Models | NAD+ | Comparison |
| 42 | NAD+ + SS-31 Research Stack: Mitochondrial Support Combinations in Lab Studies | NAD+ | Supporting |
| 43 | NAD+ Precursor Research: Biosynthesis Pathways and Cellular Energy Studies | NAD+ | Supporting |
| 44 | MOTS-C vs NAD+: Comparing Mitochondrial and Metabolic Research Approaches | MOTS-C | Comparison |
| 45 | MOTS-C Research 2026: Updated Findings on Mitochondrial Peptide Activity | MOTS-C | Supporting |
🟢 TIER 4 — Weeks 8–11 | Cluster Depth & Remaining Supporting Articles
Fills remaining gaps across cagrilintide, AOD, sermorelin, IGF-1, selank, and wolverine stack.
| # | Title | Cluster | Type |
|---|---|---|---|
| 46 | Cagrilintide Mechanism of Action: Amylin Receptor Agonism in Metabolic Research | Cagrilintide | Supporting |
| 47 | Cagrilintide Research Dosage Protocols in Preclinical Rodent Models | Cagrilintide | Supporting |
| 48 | AOD-9604 + Tesamorelin Research Stack: GHRH and HGH Fragment Combinations | AOD-9604 | Supporting |
| 49 | AOD-9604 Lipid Metabolism Research: Adipogenesis Inhibition in Cell Culture Models | AOD-9604 | Supporting |
| 50 | Sermorelin + Ipamorelin Research Stack: Combined GHRH/GHRP Lab Protocols | Sermorelin | Supporting |
| 51 | CJC-1295 Research 2026: Updated Preclinical Findings and Protocol Notes | CJC-1295 | Supporting |
| 52 | IGF-1 LR3 Research Applications in Satellite Cell and Myogenesis Studies | IGF-1 LR3 | Supporting |
| 53 | IGF-1 LR3 Dosage Protocols in Preclinical Animal and Cell Culture Studies | IGF-1 LR3 | Supporting |
| 54 | IGF-1 LR3 vs Hexarelin: Comparing Growth Factor Research Approaches | IGF-1 LR3 | Comparison |
| 55 | Longevity Peptide Research Stack 2026: SS-31, MOTS-C, and NAD+ | Longevity | Hub |
| 56 | Selank and GABA Modulation: What In Vitro Binding Research Shows | Selank | Supporting |
| 57 | Selank Anxiety Research: Key Findings from Rodent Behavioral Models | Selank | Supporting |
| 58 | Selank Dose-Response Research: Behavioral and Biomarker Outcomes in Rodent Models | Selank | Supporting |
| 59 | BPC-157 + TB-500 Wolverine Stack: Dosage Protocols Used in Preclinical Research | Wolverine Stack | Supporting |
| 60 | Wolverine Stack Storage & Reconstitution: Lab Best Practices for BPC-157 + TB-500 | Wolverine Stack | Supporting |
🔵 TIER 5 — Weeks 10–13 | Cornerstone Authority + New Clusters
Long-form reference pages that rank for years and earn backlinks. New clusters = early-mover SEO advantage.
| # | Title | Cluster | Type |
|---|---|---|---|
| 61 | The Complete Guide to Research Peptide Storage: Temperature, Reconstitution and Shelf Life | General | Cornerstone |
| 62 | Research Peptide Purity Standards: What Every Lab Should Know About HPLC, MS and COAs | General | Cornerstone |
| 63 | Peptide Half-Life Guide: How Stability Differs Across 15 Major Research Compounds | General | Cornerstone |
| 64 | The Researcher's Glossary: 100 Peptide Science Terms Defined | General | Cornerstone |
| 65 | Research Peptide Legal Status 2026: Updated Regulatory Overview by Compound | General | Cornerstone |
| 66 | BPC-157 + GHK-Cu Research Stack: Tissue Repair and Skin Regeneration Findings | Cross-Cluster | Comparison |
| 67 | Epithalon Research Peptide: Telomere Studies and Anti-Aging Preclinical Data | Epithalon 🆕 | New Cluster |
| 68 | Thymosin Alpha-1 Research: Immune Modulation in Preclinical Models | Thymosin 🆕 | New Cluster |
| 69 | Pinealon Research Peptide: Neuroprotective and Anti-Aging Preclinical Studies | Pinealon 🆕 | New Cluster |
| 70 | Dihexa Research Peptide: Synaptic Growth and Cognitive Research Overview | Dihexa 🆕 | New Cluster |
Palmetto Peptides — Phase 3 Content Plan — Internal Reference — April 23, 2026